HealthCare Royalty ("HCRx") is a leading royalty acquisition company focused on commercial or near-commercial stage biopharmaceutical products. HCRx has raised over $6.3 billion in cumulative capital commitments and has offices in Stamford (CT), San Francisco, Boston and London.  The HCRx team consists of 32 individuals (including our Senior Advisors), including former pharmaceutical executives, scientists, physicians, bankers, research analysts and consultants. 

Our philosophy is simple - We are asset-focused investors seeking to identify compelling investment opportunities that will generate long-term value. We target healthcare assets with significant clinical value and strong barriers to entry that are meaningful to their marketer. We also look for assets that will produce sustainable revenues over an extended period of time. Our investments span the pharmaceutical, biotechnology and specialty pharmaceuticals sectors.

Our investment platform is designed to serve as a long-term capital resource for our partners; flexible and directly aligned with their business models and objectives. Our team utilizes multiple investment approaches to help our partners achieve their goals including: customized debt, royalty monetization, and revenue participation financings. Since 2003, HCRx's senior professionals have completed more than 60 healthcare investments.

HEALTHCARE ROYALTY® IS A REGISTERED TRADEMARK OF HEALTHCARE ROYALTY MANAGEMENT, LLC.

HealthCare Royalty

Clarke Futch

Chris White

Michele Romaniello

Marc Kozin

Andrew Logerfo

Timothy Bryant

Rosa Mercado

Lauren Jorgensen

Tony Rapsomanikis

Carlos Almodóvar

The Leadership Team at HealthCare Royalty drives the strategic vision and operational execution of the company. Comprised of seasoned executives with diverse backgrounds in pharmaceuticals and finance, this team is responsible for identifying investment opportunities, managing stakeholder relationships, and ensuring compliance with industry regulations. They collaborate to align the company’s investment strategies with market needs, fostering sustainable growth and long-term value for partners and investors.

Leadership Team

The Finance and Accounting team at HealthCare Royalty is responsible for managing the company's financial operations, including budgeting, forecasting, financial reporting, and compliance. This team ensures the accuracy of financial records, supports investment decision-making through detailed financial analysis, and aligns financial strategies with HCRx's long-term investment objectives. Their expertise helps optimize the capital resources deployed in healthcare investments, ensuring sustainable revenue generation for the company and its partners.

Finance and Accounting

The Business Development team at HealthCare Royalty focuses on identifying and cultivating strategic partnerships and investment opportunities within the biopharmaceutical sector. They leverage their extensive industry expertise to evaluate potential assets, negotiate terms, and align investments with the company's long-term goals, ensuring strong returns and sustainable revenue streams for partners.

Business Development

The Legal and Compliance team at HealthCare Royalty ensures that all investment activities adhere to regulatory standards and internal policies. They provide legal guidance on transactions, protect intellectual property rights, and oversee compliance with healthcare regulations, thereby mitigating risks and safeguarding the firm's interests in the biopharmaceutical sector. This team plays a crucial role in maintaining HCRx's integrity and supporting the company's strategic objectives.

HealthCare Royalty

Org chart

Teams

Leadership Team

Finance and Accounting

Business Development

Legal and Compliance

Offices

HealthCare Royalty

Org chart

Teams

Leadership Team

Finance and Accounting

Business Development

Legal and Compliance

Offices

Related companies